Compare Mattel Inc (MAT) vs Novavax Inc (NVAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mattel Inc vs Novavax Inc — how do they compare? Mattel Inc trades at $15.03 (market cap $4.30B), while Novavax Inc trades at $7.97 (market cap $1.31B). The key difference: Mattel Inc is far larger — about 3.3× Novavax Inc's market cap, and Novavax Inc is trading nearer its 52-week high, Mattel Inc nearer its low. Which is the better fit depends on your goals.
| MAT | NVAX | |
|---|---|---|
Market Cap | $4.30B | $1.31B |
Sector | Consumer Cyclical | Health |
52-Week High | $22.16 | $11.19 |
52-Week Low | $13.05 | $6.22 |
Enterprise Value | $6.52B | $889.30M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Mattel Inc
Mattel markets toy products that are sold to its wholesale customers and direct to retail consumers. The company offers products for children and families, including toys for infants and preschoolers, girls and boys, youth electronics, handheld and other games, puzzles, educational toys, media-driven products, and plush and fashion-related toys. Mattel's owned portfolio includes Barbie, Hot Wheels, Fisher-Price, Thomas & Friends, and American Girl. In addition, it currently manufactures toy products for its segments both internally and externally (through manufacturing partners). Just over half of its net sales are in North America, while the remainder stem from international markets.
Read more on MAT →About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →
